BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang YG, Liu J, Shi M, Chen FX. LncRNA DGCR5 represses the development of hepatocellular carcinoma by targeting the miR-346/KLF14 axis. J Cell Physiol 2018;234:572-80. [PMID: 30216442 DOI: 10.1002/jcp.26779] [Cited by in Crossref: 24] [Cited by in F6Publishing: 35] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Lyu X, Ding X, Ye H, Guo R, Wu M, Cao L. KLF14 targets ITGB1 to inhibit the progression of cervical cancer via the PI3K/AKT signalling pathway. Discov Onc 2022;13. [DOI: 10.1007/s12672-022-00494-1] [Reference Citation Analysis]
2 Zhang Y, Zhao W, Na F, Li M, Tong S. LINC01354/microRNA-216b/KRAS Axis Promotes the Occurrence and Metastasis of Endometrial Cancer. Nanoscale Res Lett 2022;17:21. [PMID: 35099637 DOI: 10.1186/s11671-021-03640-w] [Reference Citation Analysis]
3 Chu J, Hu XC, Li CC, Li TY, Fan HW, Jiang GQ. KLF14 alleviated breast cancer invasion and M2 macrophages polarization through modulating SOCS3/RhoA/Rock/STAT3 signaling. Cell Signal 2022;:110242. [PMID: 34998931 DOI: 10.1016/j.cellsig.2022.110242] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
4 Shen W, Ge S, Liu X, Yu Q, Jiang X, Wu Q, Tian Y, Gao Y, Liu Y, Wu C. Folate-functionalized SMMC-7721 liver cancer cell membrane-cloaked paclitaxel nanocrystals for targeted chemotherapy of hepatoma. Drug Deliv 2022;29:31-42. [PMID: 34962215 DOI: 10.1080/10717544.2021.2015481] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
5 Mou X, Liew SW, Kwok CK. Identification and targeting of G-quadruplex structures in MALAT1 long non-coding RNA. Nucleic Acids Res 2021:gkab1208. [PMID: 34904666 DOI: 10.1093/nar/gkab1208] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
6 Shi T, Morishita A, Kobara H, Masaki T. The Role of Long Non-Coding RNA and microRNA Networks in Hepatocellular Carcinoma and Its Tumor Microenvironment. Int J Mol Sci 2021;22:10630. [PMID: 34638971 DOI: 10.3390/ijms221910630] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Zhang X, Yao J, Shi H, Gao B, Zhou H, Zhang Y, Zhao D, Gao S, Wang C, Zhang L. Hsa_circ_0026628 promotes the development of colorectal cancer by targeting SP1 to activate the Wnt/β-catenin pathway. Cell Death Dis 2021;12:802. [PMID: 34420031 DOI: 10.1038/s41419-021-03794-6] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
8 Xia H, Huang Z, Liu S, Zhao X, He R, Wang Z, Shi W, Chen W, Li Z, Yu L, Huang P, Kang P, Su Z, Xu Y, Yam JWP, Cui Y. LncRNA DiGeorge syndrome critical region gene 5: A crucial regulator in malignant tumors. Biomed Pharmacother 2021;141:111889. [PMID: 34323697 DOI: 10.1016/j.biopha.2021.111889] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
9 Zhong GX, Luo D, Fan YJ, Wang J, Liu BQ, Xu ZH, Zhang X. LncRNA DGCR5 Isoform-1 Silencing Suppresses the Malignant Phenotype of Clear Cell Renal Cell Carcinoma via miR-211-5p/Snail Signal Axis. Front Cell Dev Biol 2021;9:700029. [PMID: 34322486 DOI: 10.3389/fcell.2021.700029] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
10 Tan X, Liu Y, Liu Y, Zhang T, Cong S. Dysregulation of long non-coding RNAs and their mechanisms in Huntington's disease. J Neurosci Res 2021;99:2074-90. [PMID: 34031910 DOI: 10.1002/jnr.24825] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
11 Du Z, Liu M, Wang Z, Lin Z, Feng Y, Tian D, Xia L. EZH2-mediated inhibition of KLF14 expression promotes HSCs activation and liver fibrosis by downregulating PPARγ. Cell Prolif 2021;54:e13072. [PMID: 34031939 DOI: 10.1111/cpr.13072] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Ren K, Sun J, Liu L, Yang Y, Li H, Wang Z, Deng J, Hou M, Qiu J, Zhao W. TP53-Activated lncRNA GHRLOS Regulates Cell Proliferation, Invasion, and Apoptosis of Non-Small Cell Lung Cancer by Modulating the miR-346/APC Axis. Front Oncol 2021;11:676202. [PMID: 33968785 DOI: 10.3389/fonc.2021.676202] [Reference Citation Analysis]
13 Ghafouri-Fard S, Gholipour M, Hussen BM, Taheri M. The Impact of Long Non-Coding RNAs in the Pathogenesis of Hepatocellular Carcinoma. Front Oncol 2021;11:649107. [PMID: 33968749 DOI: 10.3389/fonc.2021.649107] [Cited by in Crossref: 4] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
14 Fang QL, Zhou JY, Xiong Y, Xie CR, Wang FQ, Li YT, Yin ZY, Luo GH. Long non-coding RNA RP11-284P20.2 promotes cell proliferation and invasion in hepatocellular carcinoma by recruiting EIF3b to induce c-met protein synthesis. Biosci Rep 2020;40:BSR20200297. [PMID: 32100822 DOI: 10.1042/BSR20200297] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
15 Liu G, Sun J, Yang ZF, Zhou C, Zhou PY, Guan RY, Sun BY, Wang ZT, Zhou J, Fan J, Qiu SJ, Yi Y. Cancer-associated fibroblast-derived CXCL11 modulates hepatocellular carcinoma cell migration and tumor metastasis through the circUBAP2/miR-4756/IFIT1/3 axis. Cell Death Dis 2021;12:260. [PMID: 33707417 DOI: 10.1038/s41419-021-03545-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
16 Fang Y, Chen JO, Zheng XX. LncRNA LINC02418 affects proliferation, migration, invasion, and apoptosis of hepatocellular carcinoma cells by regulating miR-940 expression. Shijie Huaren Xiaohua Zazhi 2021; 29(2): 65-74 [DOI: 10.11569/wcjd.v29.i2.65] [Reference Citation Analysis]
17 Yuan D, Chen Y, Li X, Li J, Zhao Y, Shen J, Du F, Kaboli PJ, Li M, Wu X, Ji H, Cho CH, Wen Q, Li W, Xiao Z, Chen B. Long Non-Coding RNAs: Potential Biomarkers and Targets for Hepatocellular Carcinoma Therapy and Diagnosis. Int J Biol Sci 2021;17:220-35. [PMID: 33390845 DOI: 10.7150/ijbs.50730] [Cited by in Crossref: 4] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
18 Liu SL, Cai C, Yang ZY, Wu ZY, Wu XS, Wang XF, Dong P, Gong W. DGCR5 is activated by PAX5 and promotes pancreatic cancer via targeting miR-3163/TOP2A and activating Wnt/β-catenin pathway. Int J Biol Sci 2021;17:498-513. [PMID: 33613108 DOI: 10.7150/ijbs.55636] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
19 Han TS, Hur K, Cho HS, Ban HS. Epigenetic Associations between lncRNA/circRNA and miRNA in Hepatocellular Carcinoma. Cancers (Basel) 2020;12:E2622. [PMID: 32937886 DOI: 10.3390/cancers12092622] [Cited by in Crossref: 16] [Cited by in F6Publishing: 45] [Article Influence: 8.0] [Reference Citation Analysis]
20 Wu Z, Wei ZH, Chen SH. LncUBE2R2-AS1 acts as a microRNA sponge of miR-302b to promote HCC progression via activation EGFR-PI3K-AKT signaling pathway. Cell Cycle 2020;19:2426-35. [PMID: 32835579 DOI: 10.1080/15384101.2020.1795991] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
21 Li Z, Yao H, Wang S, Li G, Gu X. CircTADA2A suppresses the progression of colorectal cancer via miR-374a-3p/KLF14 axis. J Exp Clin Cancer Res 2020;39:160. [PMID: 32799891 DOI: 10.1186/s13046-020-01642-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
22 Wu X, Hou P, Qiu Y, Wang Q, Lu X. Large-Scale Analysis Reveals the Specific Clinical and Immune Features of DGCR5 in Glioma. Onco Targets Ther 2020;13:7531-43. [PMID: 32801772 DOI: 10.2147/OTT.S257050] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
23 Shao C, Liu G, Zhang X, Li A, Guo X. Long Noncoding RNA RMRP Suppresses the Tumorigenesis of Hepatocellular Carcinoma Through Targeting microRNA-766. Onco Targets Ther 2020;13:3013-24. [PMID: 32308432 DOI: 10.2147/OTT.S243736] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
24 Pan S, Wu W, Ren F, Li L, Li Y, Li W, Wang A, Liu D, Dong Y. MiR-346-5p promotes colorectal cancer cell proliferation in vitro and in vivo by targeting FBXL2 and activating the β-catenin signaling pathway. Life Sciences 2020;244:117300. [DOI: 10.1016/j.lfs.2020.117300] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
25 Wu S, Chen S, Lin N, Yang J. Long non-coding RNA SUMO1P3 promotes hepatocellular carcinoma progression through activating Wnt/β-catenin signalling pathway by targeting miR-320a. J Cell Mol Med 2020;24:3108-16. [PMID: 31970876 DOI: 10.1111/jcmm.14977] [Cited by in Crossref: 8] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
26 Tan N, Zhu B, Shu H, Tao YF, Wu JR, Fang M, Li CR, Chen ZQ, Ou C. Effect of lncRNA‑BC200 on proliferation and migration of liver cancer cells in vitro and in vivo. Oncol Rep 2020;43:461-70. [PMID: 31894342 DOI: 10.3892/or.2019.7447] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
27 Li Y, Xu J, Zhang J, Zhang J, Zhang J, Lu X. MicroRNA-346 inhibits the growth of glioma by directly targeting NFIB. Cancer Cell Int 2019;19:294. [PMID: 31807116 DOI: 10.1186/s12935-019-1017-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
28 Yao X, You G, Zhou C, Zhang D. LncRNA ASB16-AS1 Promotes Growth And Invasion Of Hepatocellular Carcinoma Through Regulating miR-1827/FZD4 Axis And Activating Wnt/β-Catenin Pathway. Cancer Manag Res 2019;11:9371-8. [PMID: 31807066 DOI: 10.2147/CMAR.S220434] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
29 Wang Z, Zhang J, Yang B, Li R, Jin L, Wang Z, Yu H, Liu C, Mao Y, You Q. Long Intergenic Noncoding RNA 00261 Acts as a Tumor Suppressor in Non-Small Cell Lung Cancer via Regulating miR-105/FHL1 Axis. J Cancer 2019;10:6414-21. [PMID: 31772674 DOI: 10.7150/jca.32251] [Cited by in Crossref: 6] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
30 Zheng Y, Yu K, Huang C, Liu L, Zhao H, Huo M, Zhang J. Integrated bioinformatics analysis reveals role of the LINC01093/miR-96-5p/ZFAND5/NF-κB signaling axis in hepatocellular carcinoma. Exp Ther Med 2019;18:3853-60. [PMID: 31641376 DOI: 10.3892/etm.2019.8046] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
31 Sun Y, Sun H. Retracted :Propofol exerts anticancer activity on hepatocellular carcinoma cells by raising lncRNA DGCR5. J Cell Physiol 2020;235:2963-72. [DOI: 10.1002/jcp.29202] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
32 Ma J, Yan H, Zhang J, Tan Y, Gu W. Long-Chain Non-Coding RNA (lncRNA) MT1JP Suppresses Biological Activities of Lung Cancer by Regulating miRNA-423-3p/Bim Axis. Med Sci Monit 2019;25:5114-26. [PMID: 31342947 DOI: 10.12659/MSM.914387] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
33 Meng H, Huang Q, Zhang X, Huang J, Shen R, Zhang B. MiR-449a regulates the cell migration and invasion of human non-small cell lung carcinoma by targeting ADAM10. Onco Targets Ther 2019;12:3829-38. [PMID: 31190882 DOI: 10.2147/OTT.S190282] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
34 Grant R, Hallett J, Forbes S, Hay D, Callanan A. Blended electrospinning with human liver extracellular matrix for engineering new hepatic microenvironments. Sci Rep 2019;9:6293. [PMID: 31000735 DOI: 10.1038/s41598-019-42627-7] [Cited by in Crossref: 27] [Cited by in F6Publishing: 35] [Article Influence: 9.0] [Reference Citation Analysis]
35 Ji D, Wang Y, Sun B, Yang J, Luo X. Long non-coding RNA MNX1-AS1 promotes hepatocellular carcinoma proliferation and invasion through targeting miR-218-5p/COMMD8 axis. Biochem Biophys Res Commun. 2019;513:669-674. [PMID: 30982576 DOI: 10.1016/j.bbrc.2019.04.012] [Cited by in Crossref: 17] [Cited by in F6Publishing: 23] [Article Influence: 5.7] [Reference Citation Analysis]